Synopsis: IT stock is in focus upon announcing a $560M acquisition of Optimum Healthcare IT and Stratus, enhancing its healthcare and insurance capabilities. The deals expand client base, strengthen digital and cloud offerings, and support cross-selling in high-growth sectors.
The Shares of the large-cap company, which specializes in AI-powered cloud services, digital transformation, data analytics, and software development, are in focus in today’s trade after it announced a definitive agreement to acquire Optimum Healthcare IT and Stratus. Here’s what Nomura, Citi, and Morgan Stanley are saying based on the acquisitions.
With a market capitalization of Rs. 5,17,508.46 Crores on the Day’s Trade, the shares of Infosys Limited jumped upto 0.3 percent, reaching a high of Rs. 1295.00 compared to its previous close of Rs. 1279.35.
What Happened
Infosys has announced its acquisition of Optimum Healthcare IT, a leading healthcare digital transformation and consulting firm recognized for driving large-scale provider transformations. This move strengthens Infosys’ capabilities in the healthcare sector, especially in partnering with health systems to deliver measurable outcomes across clinical and operational environments.
The acquisition brings Optimum Healthcare IT’s deep provider expertise and proven delivery model to Infosys, expanding its client base and technology offerings. It also creates synergies that enhance Infosys’ growth strategy in the healthcare provider segment.
Healthcare organizations served by Optimum will now gain access to Infosys’ broader solutions, including Topaz AI, Cobalt cloud offerings, cloud engineering, infrastructure services, cybersecurity, and application transformation services.
Salil Parekh, CEO of Infosys, said that combining Optimum Healthcare IT’s deep healthcare expertise with Infosys Topaz and Cobalt will create a unique value for providers, accelerating cloud, data, and digital transformation at scale. He welcomed Optimum and its leadership to Infosys, highlighting their shared vision for the future of healthcare.
Gene Scheurer, CEO and Co-Founder of Optimum Healthcare IT, said, From the beginning, Optimum was built to deliver results through a focus on execution, collaboration, and quality. With Infosys’ long-term investment and global scale behind us, we’re positioned to accelerate AI and digital-led growth and expand what we can deliver while remaining anchored in the values, service model, and healthcare focus our clients count on.
The company will acquire Optimum Healthcare IT for up to $465 million and Stratus for up to $95 million, the Bengaluru-headquartered company said in a release.
Infosys’ second acquisition of Stratus, a New Jersey-based firm with 450+ employees specializing in Guidewire services for property and casualty insurers, strengthens its insurance capabilities. Along with Optimum Healthcare IT, these targeted, mid-sized deals reflect Infosys’ strategy of building depth in specific verticals rather than pursuing large, broad-based acquisitions. Here are Brokerage Views on the Acquisition
Citi on Infosys
The global brokerage firm Citi has maintained a Neutral rating on the stock, with a target price of Rs. 1,395, representing a 9 percent upside from the current price.
Acquisitions of Optimum Healthcare IT and Stratus – Strengthens presence in healthcare IT and digital services by expanding the client base and capabilities. Supports cross-selling and entry into high-growth niches, enhancing competitive positioning.
~1.6% Revenue Addition – Provides a modest immediate boost to top-line growth. While not transformative, it helps diversify revenue streams and reduces dependency on legacy segments.
Rise in M&A Activity – Reflects broader industry consolidation as Indian IT firms aim to acquire technology capabilities, scale, and market share, signaling a more aggressive growth strategy.
Profitability & Sustainability – Monitoring margins and growth of acquired businesses is critical. Sustainable profitability will determine if acquisitions meaningfully contribute to long-term financial health.
Integration Risks – Indian IT firms have had mixed success integrating acquisitions. Operational, cultural, and execution challenges may delay synergy realization or limit expected benefits.
Morgan Stanley on Infosys
The global brokerage firm Morgan Stanley has maintained a Equal-weight rating on the stock, with a target price of Rs. 1,760, representing a 38 percent upside from the current price.
Revenue Contribution (~1.2% of FY27) – These acquisitions are expected to add modestly to revenue, primarily by expanding service offerings and client base. While the impact on overall top-line growth is limited, it strengthens sector presence and cross-selling opportunities.
Neutral to Slightly Dilutive to Earnings – Short-term earnings may see pressure due to acquisition-related costs, integration expenses, and amortization of intangible assets. Over time, synergies and operational efficiencies could offset initial dilution.
Optimum Deal Pending Regulatory Approval – The deal’s completion relies on regulatory clearance, introducing uncertainty in timing. Delays could affect expected revenue and synergy realization, highlighting the importance of monitoring approvals closely.
More Aggressive Acquisition Strategy – Targeting niche, tuck-in acquisitions reflects a deliberate strategy to acquire specialized capabilities, accelerate digital transformation, and strengthen competitive positioning in high-growth areas of IT services.
Nomura on Infosys
The global brokerage firm Nomura has maintained a Buy rating on the stock, with a target price of Rs. 1,810, representing a 42 percent upside from the current price.
$560 Million Acquisitions (~225 bps Revenue Boost) – These deals are expected to contribute meaningfully to FY27 revenue growth, providing immediate scale and incremental top-line expansion.
Strengthens Life Sciences & Healthcare Capabilities – Expands expertise in high-growth sectors, enabling cross-selling, specialized solutions, and deeper client relationships in healthcare and life sciences IT services.
Retains Infosys as Top Large-Cap IT Pick – Strategic acquisitions reinforce long-term growth prospects and competitive positioning, supporting the stock’s attractiveness among large-cap IT companies.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
The post Infosys Share: How will the $560 Mil Optimum Healthcare acquisition benefit the company? appeared first on Trade Brains.